Informed choice vs. no choice in colorectal cancer screening tests: A prospective cohort study in real-life screening practice

American Journal of Gastroenterology

Volumn 109, Issue 7, 2014, Pages 1072-1079

  Wong, Martin C S ^a,b   Ching, Jessica Y L ^a   Chan, Victor C W ^a   Lam, Thomas Y T ^a   Luk, Arthur K C ^a   Ng, Siew C ^a   Ng, Simon S M ^a   Sung, Joseph J Y ^a  

^a Prince of Wales Hospital   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; ENDOSCOPY; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING TEST;

AGED; CHOICE BEHAVIOR; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; INFORMED CONSENT; MALE; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES;

EID: 84903901418     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.136     Document Type: Article

References (36)

1. Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
2. Hardcastle JD, Chamberlain JO, Robinson MH et al. R an d o m ised co n tro l-led trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
3. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results af er 13 years and seven biennial screening rounds. Gut 2002;50:29-32.
4. Mandel JS, Church TR, Ederer F et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7.
5. Nishihara R, Wu K, Lochhead P et al. Long-term colorectal-cancer incidence and mortality afer lower endoscopy. N Engl J Med 2013;369: 1095-105.
6. Zauber AG, Winawer SJ, O′ Brien MJ et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687-96.
7. USPreventiveServicesTaskForces. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002;137:129-31.
8. Sung JJ, Lau JY, Young GP, et al., for The Asia Pacif c Working Group on Colorectal Cancer. Asia Pacif c consensus recommendations for colorectal cancer screening. Gut 2008;57:1166-76.
9. Hewitson P, Glasziou P, Irwig L et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007;27:CD001216.
10. Vijan S, Hwang EW, Hofer TP et al. Which colon cancer screening test? A comparison of costs efectiveness, and compliance. Am J Med 2001;111:593-601.
11. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology 1995;109:1781-90.
12. Howard K, Salkeld G, Irwig L et al. High participation rates are not necessary for cost-effective colorectal cancer screening. J Med Screen 2005;12:96-102.
13. Frazier AL, Colditz GA, Fuchs CS et al. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000; 284: 1954-61.
14. Edwards BK, Ward E, Kohler BA et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544-73.
15. Schwartz B. The Paradox of Choice. Harper Collins: New York, NY, 2004.
16. Jones RM, Vernon SW, Woolf SH. Is discussion of colorectal cancer screening options associated with heightened patient confusion? Cancer Epidemiol Biomarkers Prev 2010;19:2821-5.
17. Inadomi JM, Vijan S, Janz NK et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 2012;172:575-82.
18. Levin TR. The importance of choosing colorectal cancer screening tests. Arch Intern Med 2012;172:582-.
19. Wong MC, Hirai HW, Luk AK et al. The knowledge of colorectal cancer symptoms and risk factors among 10, 078 screening participants: are high risk individuals more knowledgeable? PLoS One 2013; 8: e60366.
20. Wong MC, Ching JY, Hirai HH et al. Perceived obstacles ofcolorectal cancer screening and their associated factors among 10, 078 Chinese participants. PLoS One 2013; 8: e70209.
21. Wong MCS, John GK, Hirai HW et al. Changes in the choice of colorectal cancer screening tests in primary care settings from 7, 845 prospectively collected surveys. Cancer Causes Control 2012;23:1541-8.
22. Wong MCS, Lam TYT, Tsoi KKF et al. A validated tool to predict colorec-tal neoplasia and inform screening choice for asymptomatic subjects. Gut 2014;63:1130-6.
23. Ng SC, Ching JYL, Chan VCW et al. Diagnostic accuracy of fecal immuno-chemical test for screening individuals with a family history of colorectal cancer. Aliment Pharmacol Ter 2013;38:835-41.
24. Wong MCS, Ching JY, Lam TY et al. Prospective cohort study of compliance with faecal immunochemical tests for colorectal cancer screening in Hong Kong. Prev Med 2013;57:227-31.
25. Wong MCS, Tsoi KKF, Ng SSM et al. A Comparison of the acceptance of Immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese. Aliment Pharmacol Ter 2010;32:74-82.
26. Segnan N, Senore C, Andreoni B et al. Randomized trial of dif erent strategies for colorectal cancer: a patient response and detection rates. J Natl Cancer Inst 2005;97:347-57.
27. MulticentreAustralianColorectal-neoplasiaScreening(MACS)Group. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med J Aust 2006;184:546-50.
28. Scott RG, Edwards JT, Fritschi L et al. Community-based screening by colonoscopy or computed tomographic colonography in asymptomatic average-risk subjects. Am J Gastroenterol 2004;99:1145-51.
29. Segnan N, Senore C, Andreoni B et al. SCORE3 Working Group-Italy. Comparing attendance and detection rate of colonoscopy with sig-moidoscopy and FIT for colorectal cancer screening. Gastroenterology 2007;132:2304-12.
30. Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the Untied States. Am J Gastroenterol 2003;98:2082-91.
31. Seef LC, Nadel MR, Klabunde CN et al. Patterns and predictors of colorectal cancer test use in the adult US population. Cancer 2004;100:2093-103.
32. O'Malley AS, Forrest CB, Feng S et al. Disparities despite coverage: gaps in colorectal cancer screening among Medicare benef ciaries. Arch Intern Med 2005;165:2129-35.
33. Rimer BK, Briss PA, Zeller PK et al. Informed decision making: what is its role in cancer screening? Cancer 2004;101:1214-28.
34. GeneralMedicalCouncil. Consent guidance: patients and doctors making decisions together. 2008. Available at: www.gmc-uk.org/guidance/ethical- guidance/consent-guidance-index.asp (accessed on 17 January 2014).
35. Zapka JM, Klabunde CN, Arora NK et al. Physicians' colorectal cancer screening discussion and recommendation patterns. Cancer Epidemiol Biomarkers Prev 2011;20:509-21.
36. InstituteofMedicine. Crossing the Quality Chasm: A New Health System for the 21st Century. National Academy Press: Washington, DC, 2001, available at: http://www.nap.edu/books/0309072808/html/index.html (accessed on 17 January 2014).